Cerevel Therapeutics: Q1 Earnings Insights Cerevel Therapeutics Hldg (NASDAQ:CERE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Benzinga · May 10, 2022
Cerevel Therapeutics Hldg's Earnings: A Preview Cerevel Therapeutics Hldg (NASDAQ:CERE) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that Cerevel Therapeutics Hldg will report an earnings per share (EPS) of $-0.41. Benzinga · Feb 28, 2022